Reply to: revisiting the role of serine metabolism in hepatic lipogenesis

Zhaoyue Zhang,Tara TeSlaa,Joshua D. Rabinowitz

DOI: https://doi.org/10.1038/s42255-023-00793-z

IF: 19.865

2023-05-12

Nature Metabolism

Abstract:replying to Yang et al. Nature Metabolism https://doi.org/10.1038/s42255-023-00792-0 (2023)

endocrinology & metabolism

What problem does this paper attempt to address?

Revisiting the role of serine metabolism in hepatic lipogenesis

Hong Yang,Cheng Zhang,Hasan Turkez,Mathias Uhlen,Jan Boren,Adil Mardinoglu

DOI: https://doi.org/10.1038/s42255-023-00792-0

IF: 19.865

2023-05-12

Nature Metabolism

Abstract:arising from Z. Zhang et al. Nature Metabolism https://doi.org/10.1038/s42255-021-00487-4 (2021)

endocrinology & metabolism
Editorial: Regulation of Lipid Metabolism in Adipose Tissue and Skeletal Muscle

Zhihao Jia,Tizhong Shan

DOI: https://doi.org/10.3389/fphys.2022.1010578

IF: 4

2022-01-01

Frontiers in Physiology

Abstract:EDITORIAL article Front. Physiol., 04 November 2022Sec. Lipid and Fatty Acid Research Volume 13 - 2022 | https://doi.org/10.3389/fphys.2022.1010578
Long-wavelength infrared photoinduced switching of a resonant tunneling diode using the intersubband transition

H. Liu,A. Steele,M. Buchanan,Z. Wasilewski

DOI: https://doi.org/10.1109/55.192756

IF: 4.8157

1992-07-01

IEEE Electron Device Letters

Abstract:Voltage switching induced by long-wavelength infrared light from a CO/sub 2/ laser was observed using a double-barrier resonant tunneling diode (RTD) biased in the bistable region and the intersubband transition (IT) between the quantum confined states. Possible optoelectronic and all-optical switching applications involving hysteresis are proposed and discussed.<<ETX>>
The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment

Xijia Zhou,Chang Tian,Yingshu Cao,Min Zhao,Ke Wang

DOI: https://doi.org/10.3389/fgene.2022.1084609

IF: 3.7

2023-01-10

Frontiers in Genetics

Abstract:Metabolic reprogramming is an important hallmark of malignant tumors. Serine is a non-essential amino acid involved in cell proliferation. Serine metabolism, especially the de novo serine synthesis pathway, forms a metabolic network with glycolysis, folate cycle, and one-carbon metabolism, which is essential for rapidly proliferating cells. Owing to the rapid development in metabolomics, abnormal serine metabolism may serve as a biomarker for the early diagnosis and pathological typing of tumors. Targeting serine metabolism also plays an essential role in precision and personalized cancer therapy. This article is a systematic review of de novo serine biosynthesis and the link between serine and folate metabolism in tumorigenesis, particularly in lung cancer. In addition, we discuss the potential of serine metabolism to improve tumor treatment.

genetics & heredity
Serine metabolism orchestrates macrophage polarization by regulating the IGF1–p38 axis

Xiao Shan,Penghui Hu,Lina Ni,Long Shen,Yanan Zhang,Zemin Ji,Yan Cui,Meihua Guo,Haoan Wang,Liyuan Ran,Kun Yang,Ting Wang,Lei Wang,Bin Chen,Zhi Yao,Yingjie Wu,Qiujing Yu

DOI: https://doi.org/10.1038/s41423-022-00925-7

2022-10-01

Cellular and Molecular Immunology

Abstract:Serine metabolism is reportedly involved in immune cell functions, but whether and how serine metabolism regulates macrophage polarization remain largely unknown. Here, we show that suppressing serine metabolism, either by inhibiting the activity of the key enzyme phosphoglycerate dehydrogenase in the serine biosynthesis pathway or by exogenous serine and glycine restriction, robustly enhances the polarization of interferon-γ-activated macrophages (M(IFN-γ)) but suppresses that of interleukin-4-activated macrophages (M(IL-4)) both in vitro and in vivo. Mechanistically, serine metabolism deficiency increases the expression of IGF1 by reducing the promoter abundance of S-adenosyl methionine-dependent histone H3 lysine 27 trimethylation. IGF1 then activates the p38-dependent JAK–STAT1 axis to promote M(IFN-γ) polarization and suppress STAT6-mediated M(IL-4) activation. This study reveals a new mechanism by which serine metabolism orchestrates macrophage polarization and suggests the manipulation of serine metabolism as a therapeutic strategy for macrophage-mediated immune diseases.

immunology
Decoding Serine Metabolism: Unveiling Novel Pathways for Evolving Cancer Therapies

Aristotle Lau,John Blenis,Guillermo Burgos-Barragan

DOI: https://doi.org/10.1158/0008-5472.can-24-0541

IF: 11.2

2024-02-18

Cancer Research

Abstract:Serine metabolism plays a pivotal role in cancer, making it an appealing therapeutic target. Two recent studies published in Nature Metabolism and Science Translational Medicine uncovered novel players and therapeutic opportunities within this crucial metabolic pathway. Papalazarou and colleagues employed genetic tools coupled with metabolomics and high-throughput imaging to identify and characterize membrane transporters involved in serine uptake and mitochondrial import in colorectal cancer. Notably, they showed that dual inhibition of these transporters in combination with impaired serine biosynthesis reduced tumor growth in xenograft models. In a parallel study, Zhang and colleagues identified isocitrate dehydrogenase I (IDH1) as a novel regulator of serine biosynthesis in non-small cell lung cancer (NSCLC). Through extensive mechanistic studies, they demonstrated that IDH1 enhances the expression of the key enzymes phosphoglycerate dehydrogenase (PHGDH) and phosphoserine aminotransferase 1 (PSAT1) via a non-canonical function independent of its enzymatic activity. Strikingly, pharmacological disruption of this novel function of IDH1 not only diminished tumor growth but also enhanced the anticancer efficacy of dietary serine restriction in mouse models of lung cancer. Together, these studies advance our mechanistic understanding of how cancer cells fulfill their serine requirements and reveal innovative therapeutic avenues to deprive tumors of this vital nutrient.

oncology
Serine Supports IL-1β Production in Macrophages Through mTOR Signaling

Siyuan Chen,Yaoyao Xia,Fang He,Jian Fu,Zhongquan Xin,Baichuan Deng,Liuqin He,Xihong Zhou,Wenkai Ren

DOI: https://doi.org/10.3389/fimmu.2020.01866

IF: 7.3

2020-08-27

Frontiers in Immunology

Abstract:Intracellular metabolic programs tightly regulate the functions of macrophages, and previous studies have shown that serine mainly shapes the macrophage function via one-carbon metabolism. However, it is unknown whether serine modulates the macrophage function independent of one-carbon metabolism. Here, we find that serine deprivation lowers interleukin (IL)-1β production and inflammasome activation, as well as reprograms the transcriptomic and metabolic profile in M1 macrophages. Intriguingly, supplementation of formate, glycine, dNTPs, and glucose cannot rescue the production of IL-1β from serine-deprived macrophages. Mechanistically, serine deprivation inhibits macrophage IL-1β production through inhibition of mechanistic target of rapamycin (mTOR) signaling. Of note, the macrophages from mice feeding serine-free diet have lower IL-1β production, and these mice also show less inflammation after LPS challenge. Collectively, our data highlight a new regulatory mechanism for serine to modulate the macrophage function.

immunology
Elucidation of the Role of SHMT2 in L-Serine Homeostasis in Hypoxic Hepa1-6 Cells

Shuo Zhang,Ruoxu He,Mingsi Zhang,Jingcheng Zhang,Mengting Wu,Guangji Zhang,Tao Jiang

DOI: https://doi.org/10.3390/ijms252111786

IF: 5.6

2024-11-03

International Journal of Molecular Sciences

Abstract:Hypoxia is a characteristic feature of malignancy; however, its effect on metabolism remains unclear. In this study, Hepa1-6 cells were cultured under hypoxic conditions and their metabolites were analyzed. Elevated levels of L-serine along with increased glycolytic activity are prominent features of hypoxia. Transcriptome sequencing revealed the downregulation of genes involved in L-serine synthesis and metabolism, which was confirmed by PCR analysis and comparison with public databases. Further experimental evidence indicates that the accumulation of L-serine under hypoxic conditions is attributable not only to enhanced glycolysis but also to a reduction in the catabolism of L-serine mediated by serine hydroxymethyltransferase 2 (SHMT2).

biochemistry & molecular biology,chemistry, multidisciplinary
Metabolic Complementation between Glucose and Amino Acid Drives Hepatic De Novo Lipogenesis and Steatosis

Yilie Liao,Lei Liu,Honghao Li,Xiaojie Bai,Fangfang Sun,Xia Xiao,Suneng Fu

DOI: https://doi.org/10.1101/2021.05.08.443229

2021-01-01

Abstract:Increased de novo lipogenesis (DNL) is a hallmark of nonalcoholic fatty liver disease (NAFLD) in obesity, but the macronutrient source for >80% carbon backbone for fatty acid synthesis has not been determined. Here we take an integrated approach to dissect nutrient metabolism, both ex vivo and in vivo . We discover a castling effect of glucose and glutamine metabolism through ex vivo isotope tracing studies that limits the entrance of glucose carbon into the glutamine-dominated tricarboxylic acid cycle (TCA) and DNL pathways. In vivo tracing studies with a high carbohydrate drink (glucose/amino acid, 3:1, w/w ) confirm dietary amino acids are twice more efficient than glucose in labeling the hepatic acetyl-CoA and fatty acid pool, and together they account for over 70% of hepatic DNL substrate. Both glucose and glutamine carbon flux into DNL pathways are increased in obese hepatocytes, and metabolic rerouting of substrate carbon toward glycogen synthesis and energy production through GYS2 and GLUD1 overexpression improves hepatic steatosis. Together, these data reveal the quantitative contribution of glucose and amino acid carbon toward hepatic DNL and the development of hepatic steatosis in obesity. ### Competing Interest Statement The authors have declared no competing interest.
Hepatic sialic acid synthesis modulates glucose homeostasis in both liver and skeletal muscle

Jun Peng,Liming Yu,Linzhang Huang,Vivian A Paschoal,Haiyan Chu,Camila O de Souza,Joseph V Varre,Da Young Oh,Jennifer J Kohler,Xue Xiao,Lin Xu,William L Holland,Philip W Shaul,Chieko Mineo,Vivian A. Paschoal,Camila O. de Souza,Joseph V. Varre,Jennifer J. Kohler,William L. Holland,Philip W. Shaul

DOI: https://doi.org/10.1016/j.molmet.2023.101812

IF: 8.568

2023-09-30

Molecular Metabolism

Abstract:Objective Sialic acid is a terminal monosaccharide of glycans in glycoproteins and glycolipids, and its derivation from glucose is regulated by the rate-limiting enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE). Although the glycans on key endogenous hepatic proteins governing glucose metabolism are sialylated, how sialic acid synthesis and sialylation in the liver influence glucose homeostasis is unknown. Studies were designed to fill this knowledge gap. Methods To decrease the production of sialic acid and sialylation in hepatocytes, a hepatocyte-specific GNE knockdown mouse model was generated, and systemic glucose metabolism, hepatic insulin signaling and glucagon signaling were evaluated in vivo or in primary hepatocytes. Peripheral insulin sensitivity was also assessed. Furthermore, the mechanisms by which sialylation in the liver influences hepatic insulin signaling and glucagon signaling and peripheral insulin sensitivity were identified. Results Liver GNE deletion in mice caused an impairment of insulin suppression of hepatic glucose production. This was due to a decrease in the sialylation of hepatic insulin receptors (IR) and a decline in IR abundance due to exaggerated degradation through the Eph receptor B4. Hepatic GNE deficiency also caused a blunting of hepatic glucagon receptor (GCGR) function which was related to a decline in its sialylation and affinity for glucagon. An accompanying upregulation of hepatic FGF21 production caused an enhancement of skeletal muscle glucose disposal that led to an overall increase in glucose tolerance and insulin sensitivity. Conclusion These collective observations reveal that hepatic sialic acid synthesis and sialylation modulate glucose homeostasis in both the liver and skeletal muscle By interrogating how hepatic sialic acid synthesis influences glucose control mechanisms in the liver, a new metabolic cycle has been identified in which a key constituent of glycans generated from glucose modulates the systemic control of its precursor.

endocrinology & metabolism
Integration of metabolomic and transcriptomic analyses reveals novel regulatory functions of the ChREBP transcription factor in energy metabolism

Jie An,Inna Astapova,Guofang Zhang,Andrew L Cangelosi,Olga Ilkayeva,Hannah Marchuk,Michael J Muehlbauer,Tabitha George,Joseph T Brozinick,Mark A Herman,Christopher B Newgard

DOI: https://doi.org/10.1101/2024.09.17.613577

2024-09-21

Abstract:Carbohydrate Response Element-Binding Protein (ChREBP) is a transcription factor that activates key genes involved in glucose, fructose, and lipid metabolism in response to carbohydrate feeding, but its other potential roles in metabolic homeostasis have not been as well studied. We used liver-selective GalNAc-siRNA technology to suppress expression of ChREBP in rats fed a high fat/high sucrose diet and characterized hepatic and systemic responses by integrating transcriptomic and metabolomic analyses. GalNAc-siChREBP-treated rats had lower levels of multiple short-chain acyl CoA metabolites compared to rats treated with GalNAc-siCtrl containing a non-targeting siRNA sequence. These changes were related to a sharp decrease in free CoA levels in GalNAc-siChREBP treated-rats, accompanied by lower expression of transcripts encoding enzymes and transporters involved in CoA biosynthesis. These activities of ChREBP likely contribute to its complex effects on hepatic lipid and energy metabolism. While core enzymes of fatty acid (FA) oxidation are induced by ChREBP knockdown, accumulation of liver acylcarnitines and circulating ketones indicate diversion of acetyl CoA to ketone production rather than complete oxidation in the TCA cycle. Despite strong suppression of pyruvate kinase and activation of pyruvate dehydrogenase, pyruvate levels were maintained, likely via increased expression of pyruvate transporters, and decreased expression of lactate dehydrogenase and alanine transaminase. GalNAc-siChREBP treatment increased hepatic citrate and isocitrate levels while decreasing levels of distal TCA cycle intermediates. The drop in free CoA levels, needed for the 2-ketoglutarate dehydrogenase reaction, as well as a decrease in transcripts encoding the anaplerotic enzymes pyruvate carboxylase, glutamate dehydrogenase, and aspartate transaminase likely contributed to these effects. GalNAc-siChREBP treatment caused striking increases in PRPP and ZMP/AICAR levels, and decreases in GMP, IMP, AMP, NaNM, NAD(P), and NAD(P)H levels, accompanied by reduced expression of enzymes that catalyze late steps in purine and NAD synthesis. ChREBP suppression also increased expression of a set of plasma membrane amino acid transporters, possibly as an attempt to replenish TCA cycle intermediates. In sum, combining transcriptomic and metabolomic analyses has revealed regulatory functions of ChREBP that go well beyond its canonical roles in control of carbohydrate and lipid metabolism to now include mitochondrial metabolism and cellular energy balance.

Physiology
Hepatic Small Ubiquitin‐Related Modifier (SUMO)–Specific Protease 2 Controls Systemic Metabolism Through SUMOylation‐Dependent Regulation of Liver–Adipose Tissue Crosstalk

Yang Liu,Xin Dou,Wei‐yu Zhou,Meng Ding,Ling Liu,Ruo‐qi Du,Liang Guo,Shu‐wen Qian,Yan Tang,Qi‐qi Yang,Dong‐ning Pan,Xiao‐ying Li,Yan Lu,Jin‐ke Cheng,Qi‐qun Tang

DOI: https://doi.org/10.1002/hep.31881

IF: 17.298

2021-09-09

Hepatology

Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background & Aims</h3><p>Nonalcoholic fatty liver disease (NAFLD), characterized by aberrant triglycerides accumulation in liver, affects the metabolism remodeling of hepatic and non‐hepatic tissues by secreting altered hepatokines. SUMO‐specific protease 2 (SENP2) is responsible for de‐SUMOylation of target protein, with broad effects on cell growth, signal transduction and developmental process. However, role of SENP2 in hepatic metabolism remains unclear.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Approach & Results</h3><p>Herein, we found that SENP2 was the most dramatically increased SENPs in the fatty liver, and its level was modulated by fed/fasted conditions. To define the role of hepatic SENP2 in metabolic regulation, we generated liver‐specific SENP2 knockout (Senp2‐LKO) mice. Senp2‐LKO mice exhibited resistance to HFD‐induced hepatic steatosis and obesity. RNA‐seq analysis showed that Senp2 deficiency upregulated genes involved in fatty acid oxidation and downregulated genes in lipogenesis in the liver. Additionally, ablation of hepatic SENP2 activated thermogenesis of adipose tissues. Improved energy homeostasis of both the liver and adipose tissues by SENP2 disruption prompted us to detect the hepatokines, with FGF21 identified as a key factor markedly elevated in Senp2‐LKO mice that maintained metabolic homeostasis. Loss of FGF21 obviously reversed the positive effects of SENP2 deficiency on metabolism. Mechanistically, by screening transcriptional factors of FGF21, PPARα was defined as the mediator for SENP2 and FGF21. SENP2 interacted with PPARα and deSUMOylated it, thereby promoting ubiquitylation and subsequent degradation of PPARα, which in turn inhibited FGF21 expression and fatty acid oxidation. Consistently, SENP2 overexpression in liver facilitated development of metabolic disorders.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our finding demonstrated key role of hepatic SENP2 in governing metabolic balance by regulating liver‐adipose tissue crosstalk, linking the SUMOylation process to metabolic regulation.</p></section>

gastroenterology & hepatology
Serine synthesis via reversed SHMT2 activity drives glycine depletion and acetaminophen hepatotoxicity in MASLD

Alia Ghrayeb,Alexandra C Finney,Bella Agranovich,Daniel Peled,Sumit Kumar Anand,M Peyton McKinney,Mahasen Sarji,Dongshan Yang,Natan Weissman,Shani Drucker,Sara Isabel Fernandes,Jonatan Fernández-García,Kyle Mahan,Zaid Abassi,Lin Tan,Philip L Lorenzi,James Traylor,Jifeng Zhang,Ifat Abramovich,Y Eugene Chen,Oren Rom,Inbal Mor,Eyal Gottlieb,Alexandra C. Finney,M. Peyton McKinney,Philip L. Lorenzi,Y. Eugene Chen

DOI: https://doi.org/10.1016/j.cmet.2023.12.013

IF: 29

2024-01-04

Cell Metabolism

Abstract:Ghrayeb et al. reveal enhanced serine synthesis via reversed serine hydroxymethyltransferase 2 (SHMT2) activity in hepatic steatosis, uncovering a mechanism for the commonly observed glycine decrease in metabolic dysfunction-associated steatotic liver disease (MASLD). This restricts glutathione synthesis and causes acetaminophen hypersensitivity, which is alleviated by dietary or genetic glycine elevation.

cell biology,endocrinology & metabolism
Glycine homeostasis requires reverse SHMT flux

Matthew J McBride,Craig J Hunter,Zhaoyue Zhang,Tara TeSlaa,Xincheng Xu,Gregory S Ducker,Joshua D Rabinowitz,Matthew J. McBride,Craig J. Hunter,Gregory S. Ducker,Joshua D. Rabinowitz

DOI: https://doi.org/10.1016/j.cmet.2023.12.001

IF: 29

2024-01-01

Cell Metabolism

Abstract:The folate-dependent enzyme serine hydroxymethyltransferase (SHMT) reversibly converts serine into glycine and a tetrahydrofolate-bound one-carbon unit. Such one-carbon unit production plays a critical role in development, the immune system, and cancer. Using rodent models, here we show that the whole-body SHMT flux acts to net consume rather than produce glycine. Pharmacological inhibition of whole-body SHMT1/2 and genetic knockout of liver SHMT2 elevated circulating glycine levels up to eight-fold. Stable-isotope tracing revealed that the liver converts glycine to serine, which is then converted by serine dehydratase into pyruvate and burned in the tricarboxylic acid cycle. In response to diets deficient in serine and glycine, de novo biosynthetic flux was unaltered, but SHMT2- and serine-dehydratase-mediated catabolic flux was lower. Thus, glucose-derived serine synthesis is largely insensitive to systemic demand. Instead, circulating serine and glycine homeostasis is maintained through variable consumption, with liver SHMT2 a major glycine-consuming enzyme.

cell biology,endocrinology & metabolism
The Role of Palmitoleic Acid in Regulating Hepatic Gluconeogenesis through SIRT3 in Obese Mice

Xin Guo,Xiaofan Jiang,Keyun Chen,Qijian Liang,Shixiu Zhang,Juan Zheng,Xiaomin Ma,Hongmei Jiang,Hao Wu,Qiang Tong

DOI: https://doi.org/10.3390/nu14071482

IF: 5.9

2022-04-01

Nutrients

Abstract:Hepatic gluconeogenesis is a crucial process to maintain glucose level during starvation. However, unabated glucose production in diabetic patients is a major contributor to hyperglycemia. Palmitoleic acid is a monounsaturated fatty acid (16:1n7) that is available from dietary sources. Palmitoleic acid exhibits health beneficial effects on diabetes, insulin resistance, inflammation, and metabolic syndrome. However, the mechanism by which palmitoleate reduces blood glucose is still unclear. SIRT3 is a key metabolism-regulating NAD+-dependent protein deacetylase. It is known that fasting elevates the expression of SIRT3 in the liver and it regulates many aspects of liver’s response to nutrient deprivation, such as fatty acid oxidation and ketone body formation. However, it is unknown whether SIRT3 also regulates gluconeogenesis. Our study revealed that palmitoleic acid reduced hepatic gluconeogenesis and the expression of SIRT3 under high-fat diet conditions. Overexpression of SIRT3 in the liver and hepatocytes enhanced gluconeogenesis. Further study revealed that SIRT3 played a role in enhancing the activities of gluconeogenic enzymes, such as PEPCK, PC, and MDH2. Therefore, our study indicated that under a high-fat diet, palmitoleic acid decreased gluconeogenesis by reducing enzymatic activities of PEPCK, PC, and MDH2 by down-regulating the expression of SIRT3.

nutrition & dietetics
Spatially resolved rewiring of mitochondria-lipid droplet interactions in hepatic lipid homeostasis.

Sun Woo Sophie Kang,Lauryn A Brown,Colin B Miller,Katherine M Barrows,Jihye L Golino,Constance M Cultraro,Daniel Feliciano,Mercedes B Cornelius-Muwanuzi,Andy D Tran,Michael Kruhlak,Alexei Lobanov,Maggie Cam,Natalie Porat-Shliom

DOI: https://doi.org/10.1101/2024.12.10.627730

2024-12-12

Abstract:Hepatic lipid accumulation, or Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), is a significant risk factor for liver cancer. Despite the rising incidence of MASLD, the underlying mechanisms of steatosis and lipotoxicity remain poorly understood. Interestingly, lipid accumulation also occurs during fasting, driven by the mobilization of adipose tissue-derived fatty acids into the liver. However, how hepatocytes adapt to increased lipid flux during nutrient deprivation and what occurs differently in MASLD is not known. To investigate the differences in lipid handling in response to nutrient deficiency and excess, we developed a novel single-cell tissue imaging (scPhenomics) technique coupled with spatial proteomics. Our investigation revealed extensive remodeling of lipid droplet (LD) and mitochondrial topology in response to dietary conditions. Notably, fasted mice exhibited extensive mitochondria-LD interactions, which were rarely observed in Western Diet (WD)-fed mice. Spatial proteomics showed an increase in PLIN5 expression, a known mediator of LD-mitochondria interaction, in response to fasting. To examine the functional role of mitochondria-LD interaction on lipid handling, we overexpressed PLIN5 variants. We found that the phosphorylation state of PLIN5 impacts its capacity to form mitochondria-LD contact sites. PLIN5 S155A promoted extensive organelle interactions, triglyceride (TG) synthesis, and LD expansion in mice fed a control diet. Conversely, PLIN5 S155E expressing cells had fewer LDs and contact sites and contained less TG. Wild-type (WT) PLIN5 overexpression in WD-fed mice reduced steatosis and improved redox state despite continued WD consumption. These findings highlight the importance of organelle interactions in lipid metabolism, revealing a critical mechanism by which hepatocytes maintain homeostasis during metabolic stress. Our study underscores the potential utility of targeting mitochondria-LD interactions for therapeutic intervention.

Cell Biology
Serine synthesis through PHGDH coordinates nucleotide levels by maintaining central carbon metabolism

Michael A. Reid,Annamarie E. Allen,Shiyu Liu,Maria V. Liberti,Pei Liu,Xiaojing Liu,Ziwei Dai,Xia Gao,Qian Wang,Ying Liu,Luhua Lai,Jason W. Locasale

DOI: https://doi.org/10.1038/s41467-018-07868-6

IF: 16.6

2018-12-01

Nature Communications

Abstract:Phosphoglycerate dehydrogenase (PHGDH) catalyzes the committed step in de novo serine biosynthesis. Paradoxically, PHGDH and serine synthesis are required in the presence of abundant environmental serine even when serine uptake exceeds the requirements for nucleotide synthesis. Here, we establish a mechanism for how PHGDH maintains nucleotide metabolism. We show that inhibition of PHGDH induces alterations in nucleotide metabolism independent of serine utilization. These changes are not attributable to defects in serine-derived nucleotide synthesis and redox maintenance, another key aspect of serine metabolism, but result from disruption of mass balance within central carbon metabolism. Mechanistically, this leads to simultaneous alterations in both the pentose phosphate pathway and the tri-carboxylic acid cycle, as we demonstrate based on a quantitative model. These findings define a mechanism whereby disruption of one metabolic pathway induces toxicity by simultaneously affecting the activity of multiple related pathways.

multidisciplinary sciences
SIRT6 regulates SREBP1c-induced glucolipid metabolism in liver and pancreas via the AMPKα-mTORC1 pathway

Che Bian,Haibo Zhang,Jing Gao,Yuxia Wang,Jia Li,Dan Guo,Wei Wang,Yuling Song,Yang Weng,Huiwen Ren

DOI: https://doi.org/10.1038/s41374-021-00715-1

IF: 5.511

2021-12-18

Laboratory Investigation

Abstract:The aim of this study was to determine the mechanism by which SIRT6 regulates glucolipid metabolism disorders. We detected histological and molecular changes in Sprague-Dawley rats as well as in BRL 3A and INS-1 cell lines subjected to overnutrition and starvation. SIRT6, SREBP1c, and glucolipid metabolism biomarkers were identified by fluorescence co-localization, real-time PCR, and western blotting. Gene silencing studies were performed. Recombinant SIRT6, AMPK agonist (AICAR), mTOR inhibitor (rapamycin), and liver X receptor (LXR) agonist (T0901317) were used to pre-treated in BRL 3A and INS-1 cells. Real-time PCR and western blotting were used to detect related proteins, and cell counting was utilized to detect proliferation. We obtained conflicting results; SIRT6 and SREBP1c appeared in both the liver and pancreas of high-fat and hungry rats. Recombinant SIRT6 alleviated the decrease in AMPKα and increase in mTORC1 (complex of mTOR, Raptor, and Rheb) caused by overnutrition. SIRT6 siRNA reversed the glucolipid metabolic disorders caused by the AMPK agonist and mTOR inhibitor but not by the LXR agonist. Taken together, our results demonstrate that SIRT6 regulates glycolipid metabolism through AMPKα-mTORC1 regulating SREBP1c in the liver and pancreas induced by overnutrition and starvation, independent of LXR.

pathology,medicine, research & experimental
Identification of Senkyunolide I as a novel modulator of hepatic steatosis and PPARα signaling in zebrafish and hamster models

Qingquan Li,Jian Sheng,Mirko Baruscotti,Zhenjie Liu,Yi Wang,Lu Zhao

DOI: https://doi.org/10.1016/j.jep.2024.118743

2024-08-27

Abstract:Ethnopharmacological relevance: Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver-related morbidity and mortality, with hepatic steatosis being the hallmark symptom. Salvia miltiorrhiza Bunge (Smil, Dan-Shen) and Ligusticum striatum DC (Lstr, Chuan-Xiong) are commonly used to treat cardiovascular diseases and have the potential to regulate lipid metabolism. However, whether Smil/Lstr combo can be used to treat NAFLD and the mechanisms underlying its lipid-regulating properties remain unclear. Purpose: To assess the feasibility and reliability of a short-term high-fat diet (HFD) induced zebrafish model for evaluating hepatic steatosis phenotype and to investigate the liver lipid-lowering effects of Smil/Lstr, as well as its active components. Methods: The phenotypic alterations of liver and multiple other organ systems were examined in the HFD zebrafish model using fluorescence imaging and histochemistry. The liver-specific lipid-lowering effects of Smil/Lstr combo were evaluated endogenously. The active molecules and functional mechanisms were further explored in zebrafish, human hepatocytes, and hamster models. Results: In 5-day HFD zebrafish, significant lipid accumulation was detected in the blood vessels and the liver, as evidenced by increased staining with Oil Red O and fluorescent lipid probes. Hepatic hypertrophy was observed in the model, along with macrovesicular steatosis. Smil/Lstr combo administration effectively restored the lipid profile and alleviated hepatic hypertrophy in the HFD zebrafish. In oleic-acid stimulated hepatocytes, Smil/Lstr combo markedly reduced lipid accumulation and cell damage. Subsequently, based on zebrafish phenotypic screening, the natural phthalide senkyunolide I (SEI) was identified as a major molecule mediating the lipid-lowering activities of Smil/Lstr combo in the liver. Moreover, SEI upregulated the expression of the lipid metabolism regulator PPARα and downregulated fatty acid translocase CD36, while a PPARα antagonist sufficiently blocked the regulatory effect of SEI on hepatic steatosis. Finally, the roles of SEI on hepatic lipid accumulation and PPARα signaling were further verified in the hamster model. Conclusions: We proposed a zebrafish-based screening strategy for modulators of hepatic steatosis and discovered the regulatory roles of Smil/Lstr combo and its component SEI on liver lipid accumulation and PPARα signaling, suggesting their potential value as novel candidates for NAFLD treatment.
Zonation of hepatic fatty acid metabolism - The diversity of its regulation and the benefit of modeling

J Schleicher,C Tokarski,E Marbach,M Matz-Soja,S Zellmer,R Gebhardt,S Schuster

DOI: https://doi.org/10.1016/j.bbalip.2015.02.004

Abstract:A pronounced heterogeneity between hepatocytes in subcellular structure and enzyme activities was discovered more than 50years ago and initiated the idea of metabolic zonation. In the last decades zonation patterns of liver metabolism were extensively investigated for carbohydrate, nitrogen and lipid metabolism. The present review focuses on zonation patterns of the latter. We review recent findings regarding the zonation of fatty acid uptake and oxidation, ketogenesis, triglyceride synthesis and secretion, de novo lipogenesis, as well as bile acid and cholesterol metabolism. In doing so, we expose knowledge gaps and discuss contradictory experimental results, for example on the zonation pattern of fatty acid oxidation and de novo lipogenesis. Thus, possible rewarding directions of further research are identified. Furthermore, recent findings about the regulation of metabolic zonation are summarized, especially regarding the role of hormones, nerve innervation, morphogens, gender differences and the influence of the circadian clock. In the last part of the review, a short collection of models considering hepatic lipid metabolism is provided. We conclude that modeling, despite its proven benefit for understanding of hepatic carbohydrate and ammonia metabolisms, has so far been largely disregarded in the study of lipid metabolism; therefore some possible fields of modeling interest are presented.

Reply to: revisiting the role of serine metabolism in hepatic lipogenesis

Revisiting the role of serine metabolism in hepatic lipogenesis

Editorial: Regulation of Lipid Metabolism in Adipose Tissue and Skeletal Muscle

Long-wavelength infrared photoinduced switching of a resonant tunneling diode using the intersubband transition

The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment

Serine metabolism orchestrates macrophage polarization by regulating the IGF1–p38 axis

Decoding Serine Metabolism: Unveiling Novel Pathways for Evolving Cancer Therapies

Serine Supports IL-1β Production in Macrophages Through mTOR Signaling

Elucidation of the Role of SHMT2 in L-Serine Homeostasis in Hypoxic Hepa1-6 Cells

Metabolic Complementation between Glucose and Amino Acid Drives Hepatic De Novo Lipogenesis and Steatosis

Hepatic sialic acid synthesis modulates glucose homeostasis in both liver and skeletal muscle

Integration of metabolomic and transcriptomic analyses reveals novel regulatory functions of the ChREBP transcription factor in energy metabolism

Hepatic Small Ubiquitin‐Related Modifier (SUMO)–Specific Protease 2 Controls Systemic Metabolism Through SUMOylation‐Dependent Regulation of Liver–Adipose Tissue Crosstalk

Serine synthesis via reversed SHMT2 activity drives glycine depletion and acetaminophen hepatotoxicity in MASLD

Glycine homeostasis requires reverse SHMT flux

The Role of Palmitoleic Acid in Regulating Hepatic Gluconeogenesis through SIRT3 in Obese Mice

Spatially resolved rewiring of mitochondria-lipid droplet interactions in hepatic lipid homeostasis.

Serine synthesis through PHGDH coordinates nucleotide levels by maintaining central carbon metabolism

SIRT6 regulates SREBP1c-induced glucolipid metabolism in liver and pancreas via the AMPKα-mTORC1 pathway

Identification of Senkyunolide I as a novel modulator of hepatic steatosis and PPARα signaling in zebrafish and hamster models

Zonation of hepatic fatty acid metabolism - The diversity of its regulation and the benefit of modeling